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Clinics 
Age and sex: 32 years old male patient. 
Previous History:  
- no preleukemia; 
- no previous malignant disease; 
- no inborn condition of note. 
Organomegaly:  
- hepatomegaly;  
- splenomegaly;  
- enlarged lymph nodes;  
- no central nervous system involvement. 
Blood 
WBC: 68.4 x 109/l; Hb: 11.7 g/dl; platelets: 120 x 109/l; 
blasts: 93% 
Bone marrow: Markedly hypercellular, erythropoiesis 
depressed, leucopoiesis hyperplastic, 83.5% blasts (PM 
1%, MY 2%, MM 3.5%, Po 0.5%, Ly 6.5%, Mono 2%, 
Eb 1%), near total replacement by blasts, 
megakaryocytes depressed, occasionally Auer rods 
seen. 
Cytopathology classification 
Cytology: Acute myeloid leukemia 
Immunophenotype: Positive for CD 34, HLDR, CD33, 
CD34, CD68, myeloperoxidase. 
Rearranged Ig or Tcr: - 
Pathology: - 
Electron microscopy: - 
Precise diagnosis: Acute myeloid leukemia, M1. 
Survival 
Date of diagnosis: 05-2006. 
Treatment: Allopurinol, Hydroxyurea, Tazocin, 
Amikacin (ADE 10, ADE 8). 
Complete remission: None; 
Treatment related death: -; 
Relapse: -; 
Phenotype at relapse: -; 
Status: Alive (05-2007 traveled to receive BMT, 
allogenic BMT on 29-08-06); 
Survival: 12 months. 
Karyotype 
Sample: BM; Culture time: 24h; Banding: G-band. 
Results: 46,XY,t(3;4)(p21;q34) 
Other molecular cytogenetic techniques: Fluorescence 
in situ hybridisation (FISH), with WCP 3 and 4 probes 
to confirm the t(3;4). To confirm the translocation of 3p 
and to exclude the translocation t(3;5)(q25;q34-35) 
FISH studies with LSI BCL6 and EGR1 SO/D5S23 
probes were performed (Vysis, Downers Grove IL, 
USA). 
Other molecular cytogenetics results: Using WCP 3 
and 4 probes we confirmed the rearranged 
chromosomes 3 and 4. Analysis with LSI BCL6 probe 
revealed one red/green fusion signal on the 3q27 allele 
in the normal chromosome 3, and a fusion signal on the 
long arm of the der(3). Hybridization with LSI 5q 
SpectrumOrange/5p SpectrumGreen probe revealed 2 
normal chromosomes 5, excluding the rearrangement 
of chromosome 5. 
Other findings 
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Comments 
A 31-year-old Kuwaiti male presented with 3-months 
history of fatigue, recurrent sore throat attacks and a 2-
day history of recurrent vomiting and loose motions. 
Physical examinations revealed left cervical 
lymphadenopaty and hepatosplenomegaly. Laboratory 
investigations showed Hb 11.7g/dl, platelets 120x109l 
and white blood cells 68.4x109l. Bone marrow smears 
were markedly hypercellular with 93% large blast cells. 
Cytochemical studies showed myeloperoxydase 
positive (60%), Sudan Black B positive (74.6%), PAS 
and non-specific esterase negative blast cells.  
On the basis of these morphological findings, a 
diagnosis of acute myeloid leukemia (FAB-M1 type) 
was made. 
3p21 is a recurrent breakpoint in MDS/AML and t-
MDS/t-AML suggesting, 3p21 site is likely to contain a 
gene (genes) involved in the pathogenesis of 
t(3;4)(p21;q34). One previous case of t(3;4)(p21;q34) 
was found in a refractory anemia, making this anomaly 
recurrent. The similar cytogenetic appearance of a rare 
t(3;4)(p21;q34) and the more frequent t(3;5)(q25;q34) 
in suboptimal preparations reinforces the utility of 
FISH technique for assessing chromosomal 
abnormalities in AML. 
 
Partial karyotypes (G-banding) demonstrating rearrangened chromosomes 3 and 4. 
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Whole chromosome paintings with rearrangened chromosomes 3 and 4 and hybridization with LSI BCL6 and LSI 5qSO/5pSG probes 
showing the fusion signal on normal chromosome 3 and on der(3) chromosome and two normal chromosomes 5. 
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